Medicine and Dentistry
Systematic Review
100%
Cystic Fibrosis
60%
Meta-Analysis
21%
Drug Therapy
21%
Pediatrics
14%
Randomized Controlled Trial
13%
Quality of Life
12%
Palivizumab
12%
Placebo
10%
Medicine
9%
Breathing
9%
Respiratory Syncytial Virus Infection
9%
Critical Illness
8%
Disease
8%
Quality of Care
8%
Intensive Care Unit
8%
Lung Clearance
8%
Intensive Care
7%
Clinician
7%
Symptom
7%
Cataract Surgery
7%
Lung Transplantation
7%
Perfluorooctanoic Acid
7%
Cataract
7%
Immunosuppressive Drug
7%
Dizziness
6%
Vertigo
6%
Clinical Trial
6%
Intraocular Pressure
6%
Decision Making
6%
Prevalence
6%
Adverse Event
6%
Healthcare Research
6%
Asthma
5%
Randomized Clinical Trial
5%
Apoplexy
5%
Clinical Health
5%
Pneumonia
5%
Diagnostic Error
5%
Health Care Provider
5%
COVID-19
5%
Keyphrases
Cystic Fibrosis
41%
Meta-analysis
30%
Strength of Evidence
18%
Systematic Meta-analysis
16%
Risk of Bias
16%
Confidence Interval
14%
Randomized Controlled Trial
13%
MEDLINE
13%
Placebo
12%
Randomized Clinical Trial
10%
Evidence-based Research
10%
Infections in children
9%
Palivizumab
9%
Respiratory Syncytial Virus Infection
9%
Evidence-based Practice Center
9%
Embase
9%
PubMed
7%
Meta-research
7%
Acid Effect
7%
Perfluorohexanoic Acid (PFHxA)
7%
Lung Transplantation
7%
Immunosuppressive Therapy
7%
Cochrane
7%
United States
6%
Atrial Fibrillation
6%
Odds Ratio
6%
Absence of Evidence
6%
Navigation Guide
6%
Waste in Research
5%
Clinical Practice Guidelines
5%
Cystic Fibrosis Foundation
5%
Systematic Literature Review
5%
Quality of Life
5%
Statins
5%